[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Blood Lancets Market by Type (Standard, Safety Blood Lancets and Vacuum Blood Lancets), and End User (Hospitals & Clinics, Blood Banks, Homecare and Others),: Global Opportunity Analysis and Industry Forecast, 2019–2026

March 2020 | 165 pages | ID: BC4B8A045609EN
Allied Market Research

US$ 5,370.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The global blood lancets market was valued at $901.30 million in 2018 and is expected to reach $1,849.30 million by 2026, registering a CAGR of 9.4% from 2019 to 2026.

Blood lancet is a disposable or single use medical device primarily used for capillary blood sampling. These devices make small punctures in the skin to obtain blood samples that is further used for diagnosis of several diseases such as diabetes hyperlipidemia, blood cholesterol and dyslipidemia. These lancets are widely used by diabetic patients. Patients can easily use these devices at their homes and monitor their blood glucose level.

The major factors driving the growth of the global blood lancets market include significant increase in prevalence of chronic diseases such as diabetes, hyperlipidemia, and dyslipidemia, and rise in inclination toward home care diagnostics, are the major factors driving the blood lancets market growth. In addition, surge in use of disposable blood lancets for painless diagnosis of blood sugar level, hemoglobin, fat level, and other essential blood components, propels the market growth. Disposable lancet prevents the risk of blood transfusion and infection transmission, thereby contributing to the market growth. However, low awareness regarding homecare lancet in developing countries is anticipated to hamper the market growth. Moreover, promising regulatory scenario positively impacts the lancet market growth, thereby, creating lucrative opportunities in the near future.

The market is segmented on the basis of type, end-user, and region. By type, it is segmented into standard, safety blood lancets, and vacuum blood lancets. Based on end user, it is classified into hospitals & clinics, blood banks, homecare and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS

By Type
  • Standard
  • Safety Blood Lancets
  • Vacuum Blood Lancets
By End-User
  • Hospitals &Clinics
  • Blood Banks
  • Homecare
  • Others
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Becton, Dickinson & Company
  • Improve Medical
      • Terumo Corporation
  • Sarstedt AG & Co.
  • F.L. Medical SRL
  • Medtronic plc
  • Haemonetics Corporation
  • Shangdong Lianfa Medical
      • Nipro Medical Corporation
  • Abbott Laboratories
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Research methodology
  1.3.1. Secondary research
  1.3.2. Primary research
  1.3.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Top player positioning
3.4. Market dynamics
  3.4.1. Drivers
    3.4.1.1. Increase in incidence of chronic diseases
    3.4.1.2. Rise in reimbursement policies
  3.4.2. Restraint
    3.4.2.1. Lack of patient awareness regarding blood lancets
  3.4.3. Opportunity
    3.4.3.1. Opportunity in developing economies

CHAPTER 4: BLOOD LANCETS MARKET, BY TYPE

4.1. Overview
  4.1.1. Market size and forecast, by type
4.2. Standard
  4.2.1. Key market trends and opportunities
  4.2.2. Market size and forecast, by region
  4.2.3. Market analysis, by country
4.3. Safety Blood Lancets
  4.3.1. Key market trends and opportunities
  4.3.2. Market size and forecast, by region
  4.3.3. Market analysis, by country
4.4. Vacuum Blood Lancets
  4.4.1. Key market trends and opportunities
  4.4.2. Market size and forecast, by region
  4.4.3. Market analysis, by country

CHAPTER 5: BLOOD LANCET MARKET, BY END USER

5.1. Overview
  5.1.1. Market size and forecast, by end user
5.2. Hospitals & Clinics
  5.2.1. Market size and forecast, by region
  5.2.2. Market analysis, by country
5.3. Blood Banks
  5.3.1. Market size and forecast, by region
  5.3.2. Market analysis, by country
5.4. Homecare
  5.4.1. Market size and forecast, by region
  5.4.2. Market analysis, by country
5.5. Others
  5.5.1. Market size and forecast, by region
  5.5.2. Market analysis, by country

CHAPTER 6: BLOOD LANCET MARKET, BY REGION

6.1. Overview
  6.1.1. Market size and forecast
6.2. North America
  6.2.1. Key market trends and opportunities
  6.2.2. Market size and forecast, by country
    6.2.2.1. U.S.
      6.2.2.1.1. U.S. market size and forecast, by type
      6.2.2.1.2. U.S. market size and forecast, by end user
    6.2.2.2. Canada
      6.2.2.2.1. Canada market size and forecast, by type
      6.2.2.2.2. Canada market size and forecast, by end user
    6.2.2.3. Mexico
      6.2.2.3.1. Mexico market size and forecast, by type
      6.2.2.3.2. Mexico market size and forecast, by end user
  6.2.3. Market size and forecast, by type
  6.2.4. Market size and forecast, by end user
6.3. Europe
  6.3.1. Key market trends
  6.3.2. Market size and forecast, by country
    6.3.2.1. Germany
      6.3.2.1.1. Germany market size and forecast, by type
      6.3.2.1.2. Germany market size and forecast, by end user
    6.3.2.2. France
      6.3.2.2.1. France market size and forecast, by type
      6.3.2.2.2. France market size and forecast, by end user
    6.3.2.3. UK
      6.3.2.3.1. UK market size and forecast, by type
      6.3.2.3.2. UK market size and forecast, by end user
    6.3.2.4. Italy
      6.3.2.4.1. Italy market size and forecast, by type
      6.3.2.4.2. Italy market size and forecast, by end user
    6.3.2.5. Rest of Europe
      6.3.2.5.1. Rest of Europe market size and forecast, by type
      6.3.2.5.2. Rest of Europe market size and forecast, by end user
  6.3.3. Market size and forecast, by type
  6.3.4. Market size and forecast, by end user
6.4. Asia-Pacific
  6.4.1. Key market trends and opportunities
  6.4.2. Market size and forecast, by country
    6.4.2.1. Japan
      6.4.2.1.1. Japan market size and forecast, by type
      6.4.2.1.2. Japan market size and forecast, by end user
    6.4.2.2. China
      6.4.2.2.1. China market size and forecast, by type
      6.4.2.2.2. China market size and forecast, by end user
    6.4.2.3. India
      6.4.2.3.1. India market size and forecast, by type
      6.4.2.3.2. India market size and forecast, by end user
    6.4.2.4. Rest of Asia-Pacific
      6.4.2.4.1. Rest of Asia-Pacific market size and forecast, by type
      6.4.2.4.2. Rest of Asia-Pacific market size and forecast, by end user
  6.4.3. Market size and forecast, by type
  6.4.4. Market size and forecast, by end user
6.5. LAMEA
  6.5.1. Key market trends and opportunities
  6.5.2. Market size and forecast, by country
    6.5.2.1. Brazil
      6.5.2.1.1. Brazil market size and forecast, by type
      6.5.2.1.2. Brazil market size and forecast, by end user
    6.5.2.2. South Africa
      6.5.2.2.1. South Africa market size and forecast, by type
      6.5.2.2.2. South Africa market size and forecast, by end user
    6.5.2.3. Saudi Arabia
      6.5.2.3.1. Saudi Arabia market size and forecast, by type
      6.5.2.3.2. Saudi Arabia market size and forecast, by end user
    6.5.2.4. Rest of LAMEA
      6.5.2.4.1. Rest of LAMEA market size and forecast, by type
      6.5.2.4.2. Rest of LAMEA market size and forecast, by end user
  6.5.3. Market size and forecast, by type
  6.5.4. Market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories.
  7.1.1. Company overview
  7.1.2. Operating business segments
  7.1.3. Product portfolio
  7.1.4. Business performance
7.2. Becton Dickinson And Company
  7.2.1. Company overview
  7.2.2. Company snapshot
  7.2.3. Operating business segments
  7.2.4. Product portfolio
  7.2.5. Business performance
7.3. F L Medical S.R.L
  7.3.1. Company overview
  7.3.2. Company snapshot
  7.3.3. Operating business segments
  7.3.4. Product portfolio
7.4. Improve Medical (Guangzhou Improve Medical Instruments Co., Ltd)
  7.4.1. Company overview
  7.4.2. Company snapshot
  7.4.3. Operating business segments
  7.4.4. Product portfolio
7.5. Nipro Medical Corporation
  7.5.1. Company overview
  7.5.2. Operating business segments
  7.5.3. Product portfolio
  7.5.4. Business performance
7.6. Medtronic Plc.
  7.6.1. Company overview
  7.6.2. Company snapshot
  7.6.3. Operating business segments
  7.6.4. Product portfolio
  7.6.5. Business performance
7.7. Owen Mumford
  7.7.1. Company overview
  7.7.2. company Snapshot
  7.7.3. Operating business segments
  7.7.4. Product portfolio
7.8. Sarstedt AG & CO.
  7.8.1. Company overview
  7.8.2. Company snapshot
  7.8.3. Operating business segments
  7.8.4. Product portfolio
7.9. SteriLance Medical
  7.9.1. Company overview
  7.9.2. Company snapshot
  7.9.3. Operating business segments
  7.9.4. Product portfolio
7.10. Terumo corporation.
  7.10.1. Company overview
  7.10.2. Company snapshot
  7.10.3. Operating business segments
  7.10.4. Product portfolio
  7.10.5. Business performance

LIST OF TABLES

TABLE 01. GLOBAL BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 02. STANDARD BLOOD LANCETS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. STANDARD MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 04. SAFETY BLOOD LANCETS MARKET BY REGION 2018–2026 ($MILLION)
TABLE 05. SAFETY BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 06. VACUUM BLOOD LANCETS MARKET BY REGION 2018–2026 ($MILLION)
TABLE 07. VACUUM BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 08. GLOBAL BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 09. BLOOD LANCET MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. GOLD BLOOD LANCET MARKET, FOR BLOOD BANKS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GOLD BLOOD LANCET MARKET, FOR HOMECARE, BY REGION, 2018–2026 ($MILLION)
TABLE 12. SILVER BLOOD LANCET MARKET, FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 13. BLOOD LANCET MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 15. U.S. BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 16. U.S. BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. CANADA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 18. CANADA BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 19. MEXICO BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 20. MEXICO BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 21. NORTH AMERICA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 22. NORTH AMERICA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 23. EUROPE BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. GERMANY BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 25. GERMANY BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. FRANCE BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 27. FRANCE BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 28. UK BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 29. UK BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. ITALY BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 31. ITALY BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 32. REST OF EUROPE BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 33. REST OF EUROPE BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 34. EUROPE BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 35. EUROPE BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. EUROPE BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 37. JAPAN BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 38. JAPAN BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39. CHINA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 40. CHINA BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 41. INDIA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 42. INDIA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 43. REST OF ASIA-PACIFIC BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 44. REST OF ASIA-PACIFIC BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. ASIA-PACIFIC BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 46. ASIA-PACIFIC BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 47. EUROPE BLOOD LANCETS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 48. BRAZIL BLOOD LANCETS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 49. BRAZIL BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 50. SOUTH AFRICA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 51. SOUTH AFRICA BLOOD LANCETS MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 52. SAUDI ARABIA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 53. SAUDI ARABIA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 54. REST OF LAMEA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 55. REST OF LAMEA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 56. LAMEA BLOOD LANCET MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 57. LAMEA BLOOD LANCET MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. ABBOTT: COMPANY SNAPSHOT
TABLE 59. ABBOTT: OPERATING SEGMENTS
TABLE 60. ABBOTT: PRODUCT PORTFOLIO
TABLE 61. BECKTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 62. BECKTON DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 63. BECKTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 64. F L: COMPANY SNAPSHOT
TABLE 65. F L: OPERATING SEGMENT
TABLE 66. F L: PRODUCT PORTFOLIO
TABLE 67. IMPROVE MEDICAL: COMPANY SNAPSHOT
TABLE 68. IMPROVE MEDICAL: PRODUCT SEGMENTS
TABLE 69. IMPROVE MEDICAL: PRODUCT PORTFOLIO
TABLE 70. NIPRO: COMPANY SNAPSHOT
TABLE 71. NIPRO : OPERATING SEGMENTS
TABLE 72. NIPRO: PRODUCT PORTFOLIO
TABLE 73. MEDTRONIC: COMPANY SNAPSHOT
TABLE 74. MEDTRONIC: OPERATING SEGMENTS
TABLE 75. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 76. OWEN: COMPANY SNAPSHOT
TABLE 77. OWEN: PRODUCT PORTFOLIO
TABLE 78. SARSTEDT: COMPANY SNAPSHOT
TABLE 79. SARSTEDT: OPERATING SEGMENTS
TABLE 80. SARSTEDT: PRODUCT PORTFOLIO
TABLE 81. STERILANCE: COMPANY SNAPSHOT
TABLE 82. STERILANCE: OPERATING SEGMENTS
TABLE 83. STERILANCE: PRODUCT PORTFOLIO
TABLE 84. TERUMO.: COMPANY SNAPSHOT
TABLE 85. TERUMO.: OPERATING SEGMENTS
TABLE 86. TERUMO.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL BLOOD LANCETS MARKET SEGMENTATION
FIGURE 02. LOW-TO- MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03. LOW BARGAINING POWER OF BUYER
FIGURE 04. MODERATE THREAT OF SUBSTITUTES
FIGURE 05. LOW-TO-MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH COMPETITIVE RIVALARY
FIGURE 07. TOP PLAYER POSITIONING, 2018
FIGURE 08. DRIVERS AND RESTRAINTS
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR HOSPITALS & CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR BLOOD BANKS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR HOMECARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BLOOD LANCET MARKET, FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. U.S. BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 14. CANADA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 15. MEXICO BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 16. GERMANY BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 17. FRANCE BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 18. UK BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 19. ITALY BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 20. REST OF EUROPE BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 21. JAPAN BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 22. CHINA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 23. INDIA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 24. REST OF ASIA-PACIFIC BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 25. BRAZIL BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 26. SOUTH AFRICA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 27. SAUDI ARABIA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 28. REST OF LAMEA BLOOD LANCETS MARKET, 2018-2026 ($MILLION)
FIGURE 29. ABBOTT LABORATORIES: NET SALES, 2016–2018 ($MILLION)
FIGURE 30. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 31. ABBOTT: REVENUE SHARE BY REGION, 2018(%)
FIGURE 32. BECKTON DICKINSON AND COMPANY: NET SALES, 2016–2018 ($MILLION, 2018 (%)
FIGURE 33. BECKTON DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 34. BECKTON DICKINSON AND COMPANY: REVENUE SHARE BY REGION,2018%
FIGURE 35. NIPRO: NET SALES, 2016–2018 ($MILLION)
FIGURE 36. NIPRO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 37. NIPRO: REVENUE SHARE BY REGION, 2018(%)
FIGURE 38. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 40. MEDTRONIC: REVENUE SHARE BY REGION 2018 (%)
FIGURE 41. TERUMO, 2016–2018 ($MILLION)
FIGURE 42. TERUMO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 43. TERUMO : REVENUE SHARE BY REGION, BY 2018%


More Publications